Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin LM. Sacco, Jun Wang, Michael T. Marty et al.|Science Advances|2020Cited by 400
Expedited Approach toward the Rational Design of Noncovalent SARS-CoV-2 Main Protease InhibitorsNaoya Kitamura, Jun Wang, M. Sacco et al.|Journal of Medicinal Chemistry|2021Cited by 168
Introduction of wild-type patched gene suppresses the oncogenic potential of human squamous cell carcinoma cell lines including A431Chika Koike, Hideo Iba, Taketoshi Mizutani et al.|Oncogene|2002Cited by 34
Structure and inhibition of the SARS-CoV-2 main protease reveals strategy for developing dual inhibitors against M <sup>pro</sup> and cathepsin LM. Sacco, Jun Wang, Chunlong Ma et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 18
Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assayZilei Xia, Jun Wang, M. Sacco et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 8